Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management

Barh, D; Aljabali, AA; Tambuwala, MM; Tiwari, S; Serrano-Aroca, A; Alzahrani, KJ; Andrade, BS; Azevedo, V; Ganguly, NK; Lundstrom, K

Barh, D (corresponding author), Inst Integrat Omics & Appl Biotechnol IIOAB, Ctr Genom & Appl Gene Technol, Nonakuri 721172, Purba Medinipur, India.; Barh, D (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Genet Ecol & Evolucao, BR-31270901 Belo Horizonte, MG, Brazil.; Lundstrom, K (corresponding author), PanTherapeutics, CH-1095 Lutry, Switzerland.

BIOMEDICINES, 2021; 9 (5):

Abstract

It is well established that pre-existing comorbid conditions such as hypertension, diabetes, obesity, cardiovascular diseases (CVDs), chronic kidney d......

Full Text Link